NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

Search

Coloplast A-S (Class B)

Chiusa

430 1.9

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

430

Massimo

432.5

Metriche Chiave

By Trading Economics

Entrata

522M

1.4B

Vendite

83M

7B

P/E

Media del settore

24.41

66.418

EPS

6.32

Rendimento da dividendi

5.19

Margine di Profitto

19.835

Dipendenti

16,983

EBITDA

309M

2.3B

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+11.86% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

5.19%

2.36%

Utili prossimi

12 mag 2026

Prossima data del Dividendo

20 mag 2026

Prossima data del' Ex Dividendo

18 mag 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-21B

97B

Apertura precedente

428.1

Chiusura precedente

430

Coloplast A-S (Class B) Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

10 apr 2026, 17:04 UTC

I principali Market Mover

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 apr 2026, 00:00 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Big Yachts, Big Bucks -- Barrons.com

10 apr 2026, 21:55 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 apr 2026, 21:01 UTC

Utili

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 apr 2026, 20:50 UTC

Discorsi di Mercato

Energy & Utilities Roundup: Market Talk

10 apr 2026, 20:50 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Basic Materials Roundup: Market Talk

10 apr 2026, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

10 apr 2026, 20:31 UTC

Discorsi di Mercato

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 apr 2026, 20:10 UTC

Acquisizioni, Fusioni, Takeovers

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 apr 2026, 19:15 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

10 apr 2026, 19:15 UTC

Discorsi di Mercato

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 apr 2026, 19:08 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

10 apr 2026, 19:08 UTC

Discorsi di Mercato

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 apr 2026, 18:38 UTC

Discorsi di Mercato

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 apr 2026, 18:25 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Precious Metals Finish With Weekly Gains -- Market Talk

10 apr 2026, 18:05 UTC

Discorsi di Mercato

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 apr 2026, 17:31 UTC

Discorsi di Mercato
Principali Notizie su Eventi

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 apr 2026, 17:26 UTC

Utili

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 apr 2026, 17:10 UTC

Discorsi di Mercato

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 apr 2026, 17:00 UTC

Principali Notizie su Eventi

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 apr 2026, 16:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

10 apr 2026, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

10 apr 2026, 16:12 UTC

Utili

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 apr 2026, 16:11 UTC

Utili

Partners Group: Traditional Programs Contributed $3.3B

10 apr 2026, 16:10 UTC

Utili

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 apr 2026, 16:10 UTC

Utili

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 apr 2026, 16:10 UTC

Utili

Partners Group 1Q New Client Demand $8.3B

10 apr 2026, 16:09 UTC

Utili

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 apr 2026, 15:54 UTC

Acquisizioni, Fusioni, Takeovers

Plenitude Completes Acquisition of Acea Energia

10 apr 2026, 15:38 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Coloplast A-S (Class B) Previsione

Obiettivo di Prezzo

By TipRanks

11.86% in crescita

Previsioni per 12 mesi

Media 901.38 DKK  11.86%

Alto 1,056 DKK

Basso 720 DKK

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Coloplast A-S (Class B) - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

8 ratings

2

Acquista

4

Mantieni

2

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat